Below are the top 10 best-rated Pharmaceutical stocks, UPDATED TODAY before 4:30 AM ET, based on the number of positive ratings by brokerage analysts.
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is the 1st best-rated stock in this segment of the market. It is rated positively by 100% of the 9 brokerage analysts covering it.ArQule, Inc. (NASDAQ:ARQL) is the 2nd best-rated stock in this segment of the market. It is rated positively by 100% of the 7 brokerage analysts covering it. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is the 3rd best-rated stock in this segment of the market. It is rated positively by 100% of the 6 brokerage analysts covering it. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is the 4th best-rated stock in this segment of the market. It is rated positively by 100% of the 6 brokerage analysts covering it. AVI BioPharma, Inc. (NASDAQ:AVII) is the 5th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is the 6th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is the 7th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.AVANIR Pharmaceuticals (NASDAQ:AVNR) is the 8th best-rated stock in this segment of the market. It is rated positively by 100% of the 4 brokerage analysts covering it. Nabi Biopharmaceuticals (NASDAQ:NABI) is the 9th best-rated stock in this segment of the market. It is rated positively by 100% of the 4 brokerage analysts covering it. NuPathe Inc (NASDAQ:PATH) is the 10th best-rated stock in this segment of the market. It is rated positively by 100% of the 4 brokerage analysts covering it.
No comments:
Post a Comment